Activity-dependent changes in MAPK activation in the Angelman Syndrome mouse model

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Angelman Syndrome (AS) is a severe neurological disorder linked to the maternal UBE3A gene.
• Ube3a protein functions as an E3 ubiquitin ligase with neuron-specific imprinting.
• The precise molecular mechanisms underlying UBE3A deficiency in AS remain unclear.

Purpose of the Study:

• To investigate the regulation of Ube3a expression by synaptic activity.
• To explore the role of Ube3a in activity-dependent signaling pathways.
• To elucidate the molecular underpinnings of Angelman Syndrome.

Main Methods:

• Utilized primary neuronal cultures and in vivo mouse models (Ube3a-YFP reporter mice).
• Applied neuronal depolarization and fear conditioning paradigms to stimulate synaptic activity.
• Assessed Ube3a expression levels and ERK1/2 phosphorylation.

Main Results:

• Neuronal depolarization increased both nuclear and cytoplasmic Ube3a levels in vitro.
• Fear conditioning induced up-regulation of both maternal and paternal Ube3a expression in vivo.
• Ube3a deficiency impaired activity-dependent increases in ERK1/2 phosphorylation.

Conclusions:

• Synaptic activity dynamically regulates Ube3a expression.
• Altered Ube3a levels impact activity-dependent kinase signaling, potentially contributing to AS pathophysiology.
• Findings offer new insights into Ube3a regulation and its role in neurological function.